NCT03609385

Brief Summary

The primary goal of the PRAISE study is to develop a diagnostic algorithm that allows the prediction of acute coronary syndrome in stroke patients with elevated levels of cardiac troponin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
254

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2018

Longer than P75 for all trials

Geographic Reach
1 country

28 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 6, 2018

Completed
26 days until next milestone

First Posted

Study publicly available on registry

August 1, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

August 1, 2018

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 26, 2022

Completed
2.5 years until next milestone

Results Posted

Study results publicly available

March 26, 2025

Completed
Last Updated

March 26, 2025

Status Verified

March 1, 2025

Enrollment Period

3.4 years

First QC Date

July 6, 2018

Results QC Date

July 15, 2024

Last Update Submit

March 25, 2025

Conditions

Keywords

stroketroponinacute coronary syndromeculprit lesion

Outcome Measures

Primary Outcomes (1)

  • Presence of Myocardial Infarction

    the diagnosis will be established by an independent endpoint committee

    within seven days of admission to hospital

Secondary Outcomes (3)

  • Mortality

    at one week and at three and twelve months after the initial event, at 12 months reported.

  • Functional Outcome

    at baseline, at one week and at three and twelve months after the initial event, 12 months reported

  • Cardiovascular Events

    at one week and at three and twelve months after the initial event, 12 months reported

Study Arms (1)

Stroke patients with elevated troponin

Patients with acute ischemic stroke (confirmed by cerebral imaging) and cardiac troponin values \> 52 ng/l or troponin values \> 14 ng/l and dynamic change \> 20% will undergo coronary angiography

Diagnostic Test: Coronary angiography

Interventions

Coronary angiographyDIAGNOSTIC_TEST

In patients eligible for participation in the study coronary angiography, echocardiography and EKG will be performed systematically.

Stroke patients with elevated troponin

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

consecutive patients with acute ischemic stroke admitted to the participating sites will be systematically screened for eligibility

You may qualify if:

  • diagnosis of ischemic stroke based on clinical and imaging information (CT or MRI)
  • diagnosis of transient ischemic attack if the initial focal neurological deficit has been examined by a neurologist and if the ABCD2-score is ≥ 4
  • Elevation of high-sensitive cardiac troponins according to the rule-in/rule-out algorithm of the 2015 ESC guidelines for NSTE-ACS, i.e. highly abnormal troponin at 0 hours (\> 52ng/l if hs-cTnT, Elecsys-Assay, or \> 52ng/l, if hs-cTnI; Architect-Assay, or \> 107 ng/l, if hs-cTnI. Dimension Vista Assay) or dynamic change \> 20% of the initial value at re-test after 3 hours with at least one value above the 99th percentile of a healthy reference population
  • ability to give informed consent
  • onset of symptoms \< 72 hours prior to hospital admission

You may not qualify if:

  • renal insufficiency (GFR \< 30 ml/min/m²)
  • contraindications for coronary angiography (e.g. manifest hyperthyroidism, allergy to contrast agent)
  • lesion size \> 100 ml (either on Diffusion Weighted Imaging on cMRI or on CT if CT is performed \> 24 hours after onset) or ASPECTS score \< 7 (on CT if CT is performed \< 24 hours after onset)
  • Premorbid degree of dependence (mRS \> 3)
  • pregnancy or breast-feeding
  • limited life expectancy \< 1 year
  • consent to participate in the study given \> 72 hours after hospital admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (28)

Rhön-Klinikum Campus Bad Neustadt

Bad Neustadt an der Saale, Germany

Location

Charité-Campus Mitte

Berlin, 10117, Germany

Location

Charité-Campus Benjamin Franklin

Berlin, 12203, Germany

Location

Charité-Campus Virchow Klinikum

Berlin, 13353, Germany

Location

Jüdisches Krankenhaus

Berlin, Germany

Location

Universitätsklinikum Bonn

Bonn, Germany

Location

Allgemeines Krankenhaus Celle

Celle, Germany

Location

Universitätsklinikum Dresden

Dresden, Germany

Location

Universitätsklinikum Erlangen

Erlangen, Germany

Location

Universitätsklinikum Frankfurt

Frankfurt, Germany

Location

Klinikum Friedrichshafen

Friedrichshafen, Germany

Location

Klinikum Fulda

Fulda, Germany

Location

Universitätsmedizin Göttingen

Göttingen, Germany

Location

Universitätsklinikum Greifswald

Greifswald, Germany

Location

Universitätsklinikum Hamburg-Eppendorf

Hamburg, Germany

Location

Universitätsklinikum Heidelberg

Heidelberg, Germany

Location

Universitätsklinikum Jena

Jena, Germany

Location

Universitätsklinikum Leipzig

Leipzig, Germany

Location

Universitätsklinikum Schleswig-Holstein, Campus Lübeck

Lübeck, Germany

Location

Universitätsklinikum Magdeburg

Magdeburg, Germany

Location

Universitätsklinikum Mannheim

Mannheim, Germany

Location

Universitätsklinikum der Ludwig-Maximilians-Universität München

Munich, Germany

Location

Technische Universität München (TUM)

München, Germany

Location

Klinikum Nürnberg Süd

Nuremberg, Germany

Location

Klinikum Osnabrück

Osnabrück, Germany

Location

Universitätsmedizin Rostock

Rostock, Germany

Location

Universitätsklinikum Tübingen

Tübingen, Germany

Location

Universitätsklinikum Ulm

Ulm, Germany

Location

Related Publications (3)

  • Nolte CH, von Rennenberg R, Litmeier S, Scheitz JF, Leistner DM, Blankenberg S, Dichgans M, Katus H, Petzold GC, Pieske B, Regitz-Zagrosek V, Wegscheider K, Zeiher AM, Landmesser U, Endres M. PRediction of acute coronary syndrome in acute ischemic StrokE (PRAISE) - protocol of a prospective, multicenter trial with central reading and predefined endpoints. BMC Neurol. 2020 Aug 27;20(1):318. doi: 10.1186/s12883-020-01903-0.

    PMID: 32854663BACKGROUND
  • Nolte CH, von Rennenberg R, Litmeier S, Leistner DM, Szabo K, Baumann S, Mengel A, Michalski D, Siepmann T, Blankenberg S, Petzold GC, Dichgans M, Katus H, Pieske B, Regitz-Zagrosek V, Braemswig TB, Rangus I, Pepic A, Vettorazzi E, Zeiher AM, Scheitz JF, Wegscheider K, Landmesser U, Endres M. Type 1 Myocardial Infarction in Patients With Acute Ischemic Stroke. JAMA Neurol. 2024 Jul 1;81(7):703-711. doi: 10.1001/jamaneurol.2024.1552.

  • von Rennenberg R, Litmeier S, Szabo K, Mengel A, Petersen M, Wunderlich S, Michalski D, Thomalla G, Kallmunzer B, Petzold G, Dichgans M, Siepmann T, Royl G, Ringleb PA, Nolte CH, Endres M. Cognitive performance in patients with ischemic stroke and additional myocardial injury - results from the multicenter prospective observational PRAISE study. Neurol Res Pract. 2025 Nov 4;7(1):84. doi: 10.1186/s42466-025-00446-4.

MeSH Terms

Conditions

Ischemic StrokeAcute Coronary SyndromeStroke

Interventions

Coronary Angiography

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesMyocardial IschemiaHeart Diseases

Intervention Hierarchy (Ancestors)

Cardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisAngiographyRadiographyDiagnostic Techniques, CardiovascularHeart Function Tests

Results Point of Contact

Title
Dr. Christian Nolte
Organization
Charité-Universitätsmedizin Berlin

Study Officials

  • Matthias Endres, Prof

    Charite University, Berlin, Germany

    PRINCIPAL INVESTIGATOR
  • Ulf Landmesser, Prof

    Charite University, Berlin, Germany

    PRINCIPAL INVESTIGATOR
  • Christian Nolte, Prof

    Charite University, Berlin, Germany

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof Dr med. Matthias Endres

Study Record Dates

First Submitted

July 6, 2018

First Posted

August 1, 2018

Study Start

August 1, 2018

Primary Completion

December 20, 2021

Study Completion

September 26, 2022

Last Updated

March 26, 2025

Results First Posted

March 26, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations